We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+23.68%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76.1M
AUM Growth
+$16.3M
Cap. Flow
+$5.33M
Cap. Flow %
7.01%
Top 10 Hldgs %
22.66%
Holding
125
New
16
Increased
31
Reduced
11
Closed
33

Top Buys

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$2.08M
2
TOST icon
Toast
TOST
+$1.97M
3
AFRM icon
Affirm
AFRM
+$1.36M
4
PACB icon
Pacific Biosciences
PACB
+$998K
5
TDOC icon
Teladoc Health
TDOC
+$936K

Top Sells

Rank Stock Value
1
APPF icon
AppFolio
APPF
+$1.11M
2
RCM
R1 RCM Inc. Common Stock
RCM
+$1.06M
3
KNSL icon
Kinsale Capital Group
KNSL
+$1.05M
4
CLH icon
Clean Harbors
CLH
+$1.02M
5
MTDR icon
Matador Resources
MTDR
+$989K

Sector Composition

Rank Sector Weight
1 Healthcare 33.27%
2 Technology 29.89%
3 Consumer Discretionary 13.95%
4 Financials 9.7%
5 Industrials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFRM icon
1
Affirm
AFRM
$23.5B
$2.31M 3.03%
+46,969
New +$1.36M
TOST icon
2
Toast
TOST
$16.8B
$2.19M 2.88%
+120,029
New +$1.97M
BILL icon
3
BILL Holdings
BILL
$4.23B
$2.07M 2.72%
+25,325
New +$2.08M
UPST icon
4
Upstart Holdings
UPST
$2.61B
$1.99M 2.61%
48,632
+29,185
+150% +$889K
TWST icon
5
Twist Bioscience
TWST
$5.56B
$1.72M 2.26%
46,647
+550
+1% +$12.7K
PD icon
6
PagerDuty
PD
$688M
$1.47M 1.93%
63,602
+23,536
+59% +$510K
PACB icon
7
Pacific Biosciences
PACB
$413M
$1.43M 1.88%
145,574
+121,999
+517% +$998K
PEGA icon
8
Pegasystems
PEGA
$4.27B
$1.38M 1.82%
56,658
+32,986
+139% +$772K
TDOC icon
9
Teladoc Health
TDOC
$1.58B
$1.37M 1.8%
63,591
+50,710
+394% +$936K
TXG icon
10
10x Genomics
TXG
$5.81B
$1.32M 1.73%
23,594
+8,773
+59% +$382K
LBRT icon
11
Liberty Energy
LBRT
$3.02B
$1.31M 1.72%
72,046
+23,581
+49% +$448K
ARVN icon
12
Arvinas
ARVN
$522M
$1.26M 1.65%
30,531
– –
ALTR
13
DELISTED
Altair Engineering Inc
ALTR
$1.18M 1.55%
14,060
-2,770
-16% -$193K
ZYXI
14
DELISTED
Zynex
ZYXI
$1.16M 1.52%
106,198
+53,795
+103% +$479K
MDGL icon
15
Madrigal Pharmaceuticals
MDGL
$12.5B
$1.16M 1.52%
4,992
+2,853
+133% +$499K
ZUO
16
DELISTED
Zuora, Inc.
ZUO
$1.12M 1.47%
119,157
+23,725
+25% +$196K
MXL icon
17
MaxLinear
MXL
$6.71B
$1.07M 1.41%
45,068
– –
PATH icon
18
UiPath
PATH
$5.4B
$1.07M 1.41%
+43,091
New +$841K
ASAN icon
19
Asana
ASAN
$1.52B
$1.05M 1.38%
55,065
+10,272
+23% +$200K
ETSY icon
20
Etsy
ETSY
$7.64B
$1.03M 1.36%
+12,768
New +$913K
PUBM icon
21
PubMatic
PUBM
$581M
$1.02M 1.35%
62,830
+18,519
+42% +$269K
WOLF icon
22
Wolfspeed
WOLF
$1.22B
$1.02M 1.34%
23,420
+18,585
+384% +$674K
CPRX
23
DELISTED
Catalyst Pharmaceutical
CPRX
$1M 1.32%
59,577
-7,490
-11% -$102K
HOOD icon
24
Robinhood
HOOD
$83.7B
$1M 1.32%
78,567
+37,188
+90% +$370K
AMRC icon
25
Ameresco
AMRC
$1.19B
$982K 1.29%
31,003
+14,537
+88% +$438K
1
2 3 4 5

Similar funds

MHWM
Montz Harcus Wealth Management New Orleans, Louisiana $248M AUM 19.43% 1-Year Est. Return
AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $247M AUM 30.07% 1-Year Est. Return

Capital Impact Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Capital Impact Advisors held 125 positions worth $76.1M, up 27% from $59.9M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Capital Impact Advisors deployed $5.33M of net new capital in Q4 2023, opening 16 new positions and adding to 31 existing holdings. Its largest new stake was BILL Holdings: 25,325 shares worth $2.07M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was e.l.f. Beauty, an estimated $474K trimmed.

  • Capital Impact Advisors's largest Q4 2023 buy was BILL Holdings: 25,325 shares worth $2.07M.
  • Capital Impact Advisors added most to Pacific Biosciences in Q4 2023, an estimated $998K increase.
  • Capital Impact Advisors's biggest Q4 2023 reduction was e.l.f. Beauty, cutting an estimated $474K.
  • Capital Impact Advisors fully exited AppFolio in Q4 2023, selling an estimated $1.11M.
  • Capital Impact Advisors's ten largest holdings make up 23% of its $76.1M portfolio in Q4 2023.
  • Capital Impact Advisors opened 16 new positions and closed 33 in Q4 2023.
  • Capital Impact Advisors's portfolio value rose 27% quarter-over-quarter to $76.1M.

Based on Capital Impact Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.